Quick Answer
Edesa Biotech, Inc. reported Earnings Per Share Diluted of $0.57 (loss) per share for the year ending 2016.
- Edesa Biotech, Inc. showed a decrease of -58.3% in Earnings Per Share Diluted from 2015 to 2016.
- This data is from Edesa Biotech, Inc.'s annual report (Form 10-K), filed with the SEC on December 14, 2016.
- XBRL data for this metric is available from 2013 to 2016 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 5 years of available data (2013 to 2016), Edesa Biotech, Inc.'s Earnings Per Share Diluted has grown by 79.7%.
- Historical annual values: Fiscal year 2016: $0.57 (loss) per share | Fiscal year 2015: $0.36 (loss) per share | Fiscal year 2014: $0.13 per share | Fiscal year 2014: $1.11 (loss) per share | Fiscal year 2013: $2.81 (loss) per share.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: